Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the

Anthony D Harris1, J Kristie Johnson, Kerri A Thom

  • 1Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.

Insights

This study investigated risk factors for intestinal colonization by imipenem-resistant Pseudomonas aeruginosa (IRPA) specifically excluding patient-to-patient spread. Findings help differentiate acquisition pathways for this challenging pathogen.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Research

Background:

  • Intestinal colonization by imipenem-resistant Pseudomonas aeruginosa (IRPA) is a growing clinical concern.
  • Acquisition pathways, including patient-to-patient transmission and antibiotic selective pressure, may have distinct risk factors.
  • Understanding non-transmission-related risk factors is crucial for effective infection control.

Purpose of the Study:

  • To identify and quantify risk factors associated with the development of intestinal colonization by IRPA.
  • To specifically investigate factors beyond direct patient-to-patient transmission.
  • To inform targeted prevention strategies for IRPA colonization.

Main Methods:

  • Retrospective cohort study design.
  • Analysis of patient data including antibiotic exposure and healthcare-associated factors.
  • Statistical modeling to identify independent risk factors.

Main Results:

  • Several factors were significantly associated with IRPA colonization independent of patient-to-patient transmission.
  • Specific antibiotic classes and duration of exposure emerged as key risk factors.
  • Patient comorbidities also played a role in colonization susceptibility.

Conclusions:

  • Antibiotic selective pressure is a significant driver of IRPA intestinal colonization.
  • Identifying non-transmission-related risk factors allows for more precise interventions.
  • This research aids in developing strategies to mitigate IRPA colonization in healthcare settings.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...